Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Dynamic changes in Id3 and E-protein activity orchestrate germinal center and plasma cell development.

Gloury R, Zotos D, Zuidscherwoude M, Masson F, Liao Y, Hasbold J, Corcoran LM, Hodgkin PD, Belz GT, Shi W, Nutt SL, Tarlinton DM, Kallies A.

J Exp Med. 2016 May 30;213(6):1095-111. doi: 10.1084/jem.20152003. Epub 2016 May 23.

2.

The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation.

Carotta S, Willis SN, Hasbold J, Inouye M, Pang SH, Emslie D, Light A, Chopin M, Shi W, Wang H, Morse HC 3rd, Tarlinton DM, Corcoran LM, Hodgkin PD, Nutt SL.

J Exp Med. 2014 Oct 20;211(11):2169-81. doi: 10.1084/jem.20140425. Epub 2014 Oct 6.

3.

Activation-induced B cell fates are selected by intracellular stochastic competition.

Duffy KR, Wellard CJ, Markham JF, Zhou JH, Holmberg R, Hawkins ED, Hasbold J, Dowling MR, Hodgkin PD.

Science. 2012 Jan 20;335(6066):338-41. doi: 10.1126/science.1213230. Epub 2012 Jan 5.

4.

The genetic network controlling plasma cell differentiation.

Nutt SL, Taubenheim N, Hasbold J, Corcoran LM, Hodgkin PD.

Semin Immunol. 2011 Oct;23(5):341-9. doi: 10.1016/j.smim.2011.08.010. Epub 2011 Sep 15. Review.

PMID:
21924923
5.

Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells.

Emslie D, D'Costa K, Hasbold J, Metcalf D, Takatsu K, Hodgkin PO, Corcoran LM.

J Exp Med. 2008 Feb 18;205(2):409-21. doi: 10.1084/jem.20072049. Epub 2008 Feb 4.

6.

Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.

Kallies A, Hasbold J, Fairfax K, Pridans C, Emslie D, McKenzie BS, Lew AM, Corcoran LM, Hodgkin PD, Tarlinton DM, Nutt SL.

Immunity. 2007 May;26(5):555-66.

7.

Decision criteria for resolving isotype switching conflicts by B cells.

Deenick EK, Hasbold J, Hodgkin PD.

Eur J Immunol. 2005 Oct;35(10):2949-55.

8.

Differential requirement for OBF-1 during antibody-secreting cell differentiation.

Corcoran LM, Hasbold J, Dietrich W, Hawkins E, Kallies A, Nutt SL, Tarlinton DM, Matthias P, Hodgkin PD.

J Exp Med. 2005 May 2;201(9):1385-96.

9.

Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.

Kallies A, Hasbold J, Tarlinton DM, Dietrich W, Corcoran LM, Hodgkin PD, Nutt SL.

J Exp Med. 2004 Oct 18;200(8):967-77.

10.

Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation.

Hasbold J, Corcoran LM, Tarlinton DM, Tangye SG, Hodgkin PD.

Nat Immunol. 2004 Jan;5(1):55-63. Epub 2003 Nov 30.

PMID:
14647274
11.

B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.

Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, Basten A, Brink R.

J Exp Med. 2003 Apr 7;197(7):845-60. Epub 2003 Mar 31.

13.
14.

Flow cytometric cell division tracking using nuclei.

Hasbold J, Hodgkin PD.

Cytometry. 2000 Jul 1;40(3):230-7.

PMID:
10878566
15.

Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester.

Hasbold J, Gett AV, Rush JS, Deenick E, Avery D, Jun J, Hodgkin PD.

Immunol Cell Biol. 1999 Dec;77(6):516-22.

PMID:
10571672
16.
18.

The logic of intercellular communication in the immune system.

Hodgkin PD, Rush J, Gett AV, Bartell G, Hasbold J.

Immunol Cell Biol. 1998 Oct;76(5):448-53.

PMID:
9797466
19.

Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice.

Cook MC, Körner H, Riminton DS, Lemckert FA, Hasbold J, Amesbury M, Hodgkin PD, Cyster JG, Sedgwick JD, Basten A.

J Exp Med. 1998 Oct 19;188(8):1503-10.

20.

Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4.

Hasbold J, Lyons AB, Kehry MR, Hodgkin PD.

Eur J Immunol. 1998 Mar;28(3):1040-51.

21.

The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice.

Johnson-Léger C, Hasbold J, Holman M, Klaus GG.

J Immunol. 1997 Aug 1;159(3):1150-9.

PMID:
9233608
22.

The importance of efficacy and partial agonism in evaluating models of B lymphocyte activation.

Hodgkin PD, Chin SH, Bartell G, Mamchak A, Doherty K, Lyons AB, Hasbold J.

Int Rev Immunol. 1997;15(1-2):101-27. Review.

PMID:
9178074
23.

Properties of mouse CD40: differential expression of CD40 epitopes on dendritic cells and epithelial cells.

Van Den Berg TK, Hasbold J, Renardel De Lavalette C, Döpp EA, Dijkstra CD, Klaus GG.

Immunology. 1996 Jun;88(2):294-300.

24.

Properties of mouse CD40: the role of homotypic adhesion in the activation of B cells via CD40.

Klaus GG, Holman M, Hasbold J.

Eur J Immunol. 1994 Nov;24(11):2714-9.

PMID:
7525301
25.

Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies.

Hasbold J, Johnson-Léger C, Atkins CJ, Clark EA, Klaus GG.

Eur J Immunol. 1994 Aug;24(8):1835-42.

PMID:
7519998
26.

Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes.

Parry SL, Holman MJ, Hasbold J, Klaus GG.

Eur J Immunol. 1994 Apr;24(4):974-9.

PMID:
7512037
27.
28.

B cells from CBA/N mice do not proliferate following ligation of CD40.

Hasbold J, Klaus GG.

Eur J Immunol. 1994 Jan;24(1):152-7.

PMID:
7517360
29.

Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.

Hasbold J, Klaus GG.

Eur J Immunol. 1990 Aug;20(8):1685-90.

PMID:
2209683

Supplemental Content

Loading ...
Support Center